Regulatory14 May 2026, 03:28 pm
Senores Pharma: Monitoring Agency Report for Q4 FY26
AI Summary
Senores Pharmaceuticals Ltd. has released the Monitoring Agency Report for the quarter ended March 31, 2026, as per SEBI regulations. The report, issued by CARE Ratings Limited, concerns the utilization of IPO proceeds. The Audit Committee and Board of Directors reviewed and recorded the report on May 14, 2026. The report indicates a delay in implementing one of the objects which was scheduled to get completed by FY26.
Key Highlights
- CARE Ratings issued the Monitoring Agency Report for Q4 FY26.
- The report concerns the utilization of ₹500 Cr IPO proceeds.
- The Audit Committee and Board reviewed the report on May 14, 2026.
- There is an ongoing delay in implementing one of the objects.
- No deviation from the objects of the issue was reported.
Price Impact
More from SENORES